S&P 500   4,345.45 (+0.36%)
DOW   34,103.26 (+0.10%)
QQQ   361.17 (+0.92%)
AAPL   176.56 (+1.51%)
MSFT   319.39 (-0.04%)
META   301.42 (+1.92%)
GOOGL   131.69 (+0.96%)
AMZN   130.80 (+1.14%)
TSLA   252.81 (-1.13%)
NVDA   418.75 (+2.09%)
NIO   8.54 (+1.07%)
BABA   88.39 (+5.09%)
AMD   97.49 (+1.44%)
T   15.17 (-0.91%)
F   12.50 (+2.46%)
MU   69.67 (+2.61%)
CGC   0.83 (+7.69%)
GE   112.46 (-0.47%)
DIS   82.12 (-0.74%)
AMC   7.98 (+3.64%)
PFE   32.69 (-0.49%)
PYPL   58.78 (+0.27%)
NFLX   382.19 (-0.51%)
S&P 500   4,345.45 (+0.36%)
DOW   34,103.26 (+0.10%)
QQQ   361.17 (+0.92%)
AAPL   176.56 (+1.51%)
MSFT   319.39 (-0.04%)
META   301.42 (+1.92%)
GOOGL   131.69 (+0.96%)
AMZN   130.80 (+1.14%)
TSLA   252.81 (-1.13%)
NVDA   418.75 (+2.09%)
NIO   8.54 (+1.07%)
BABA   88.39 (+5.09%)
AMD   97.49 (+1.44%)
T   15.17 (-0.91%)
F   12.50 (+2.46%)
MU   69.67 (+2.61%)
CGC   0.83 (+7.69%)
GE   112.46 (-0.47%)
DIS   82.12 (-0.74%)
AMC   7.98 (+3.64%)
PFE   32.69 (-0.49%)
PYPL   58.78 (+0.27%)
NFLX   382.19 (-0.51%)
S&P 500   4,345.45 (+0.36%)
DOW   34,103.26 (+0.10%)
QQQ   361.17 (+0.92%)
AAPL   176.56 (+1.51%)
MSFT   319.39 (-0.04%)
META   301.42 (+1.92%)
GOOGL   131.69 (+0.96%)
AMZN   130.80 (+1.14%)
TSLA   252.81 (-1.13%)
NVDA   418.75 (+2.09%)
NIO   8.54 (+1.07%)
BABA   88.39 (+5.09%)
AMD   97.49 (+1.44%)
T   15.17 (-0.91%)
F   12.50 (+2.46%)
MU   69.67 (+2.61%)
CGC   0.83 (+7.69%)
GE   112.46 (-0.47%)
DIS   82.12 (-0.74%)
AMC   7.98 (+3.64%)
PFE   32.69 (-0.49%)
PYPL   58.78 (+0.27%)
NFLX   382.19 (-0.51%)
S&P 500   4,345.45 (+0.36%)
DOW   34,103.26 (+0.10%)
QQQ   361.17 (+0.92%)
AAPL   176.56 (+1.51%)
MSFT   319.39 (-0.04%)
META   301.42 (+1.92%)
GOOGL   131.69 (+0.96%)
AMZN   130.80 (+1.14%)
TSLA   252.81 (-1.13%)
NVDA   418.75 (+2.09%)
NIO   8.54 (+1.07%)
BABA   88.39 (+5.09%)
AMD   97.49 (+1.44%)
T   15.17 (-0.91%)
F   12.50 (+2.46%)
MU   69.67 (+2.61%)
CGC   0.83 (+7.69%)
GE   112.46 (-0.47%)
DIS   82.12 (-0.74%)
AMC   7.98 (+3.64%)
PFE   32.69 (-0.49%)
PYPL   58.78 (+0.27%)
NFLX   382.19 (-0.51%)
NASDAQ:FTXH

First Trust Nasdaq Pharmaceuticals ETF (FTXH) Price, Holdings, & News

$25.97
-0.08 (-0.31%)
(As of 09:46 AM ET)
Compare
Today's Range
$25.97
$26.04
50-Day Range
$25.96
$27.18
52-Week Range
$23.87
$28.59
Volume
507 shs
Average Volume
12,924 shs
Market Capitalization
$24.67 million
Assets Under Management
$20.86 million
Dividend Yield
1.66%
Net Expense Ratio
0.60%
FTXH stock logo

About First Trust Nasdaq Pharmaceuticals ETF (NASDAQ:FTXH)

The First Trust Nasdaq Pharmaceuticals ETF (FTXH) is an exchange-traded fund that is based on the Nasdaq US Smart Pharmaceuticals index. The fund tracks the 30 most liquid US pharmaceutical companies, weighted according to factors related to value, volatility, and growth. FTXH was launched on Sep 20, 2016 and is managed by First Trust.

FTXH Price History

FTXH ETF News Headlines

This Stock Could Go Up 66% or More.
Marc Chaikin built the system that isolated NVDA before it became the best-performing stock of 2023.  Click here to get his latest buy.  More here.
Solid Q4 Earnings Fail to Impress Pharma ETFs
This Stock Could Go Up 66% or More.
Marc Chaikin built the system that isolated NVDA before it became the best-performing stock of 2023.  Click here to get his latest buy.  More here.
See More Headlines
Receive FTXH Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for First Trust Nasdaq Pharmaceuticals ETF and its competitors with MarketBeat's FREE daily newsletter.

Fund Details

Issuer
First Trust
Fund Name
First Trust Nasdaq Pharmaceuticals ETF
Tax Classification
Regulated Investment Company
Current Symbol
NASDAQ:FTXH
Inception Date
9/20/2016
Fund Manager
Daniel J. Lindquist, Jon Erickson David McGarel, RogerTestin, Stan Ueland, Chris Peterson, Erik Russo
Web
N/A

Fund Focus

Asset Class
Equity
Benchmark
Nasdaq US Smart Pharmaceuticals Index
Category
Sector
Focus
Health Care
Development Level
Developed Markets
Region
North America
Number of Holdings
50

Fund Statistics

Assets Under Management
$21.10 million
Average Daily Volume
$12,360.10
Discount/Premium
-0.03%

Administrator, Advisor and Custodian

Administrator
Brown Brothers Harriman & Co.
Advisor
First Trust Advisors L.P.
Custodian
Brown Brothers Harriman & Co.
Distributor
First Trust Portfolios L.P.
Transfer Agent
Brown Brothers Harriman & Co.
Trustee
N/A
Lead Market Maker
Credit Suisse

Options

Optionable
N/A
Short Interest
8,300 shs

Miscellaneous

Beta
0.70
Creation Unit
50,000
Creation Fee
$500.00
Elon Musk's Next Move Cover

Wondering when you'll finally be able to invest in SpaceX, StarLink or The Boring Company? Click the link below to learn when Elon Musk will let these companies finally IPO.

Get This Free Report

First Trust Nasdaq Pharmaceuticals ETF Expenses

TypeFTXHHealth Care ETFsEquity ETFsNASDAQ ETFsAll ETFs
Management Fee0.60%0.57%0.53%0.47%0.50%
Other Expenses0.00%0.40%0.52%0.29%0.57%
Total Expense0.60%0.72%0.69%0.56%0.69%
Fee Waiver0.00%-0.51%-0.55%-0.22%-0.59%
Net Expense0.60%0.61%0.59%0.52%0.57%

First Trust Nasdaq Pharmaceuticals ETF (FTXH) Holdings & Exposure

FTXH Sector Exposure

FTXH Industry Exposure














FTXH ETF - Frequently Asked Questions

How have FTXH shares performed in 2023?

First Trust Nasdaq Pharmaceuticals ETF's stock was trading at $27.4310 at the beginning of 2023. Since then, FTXH stock has decreased by 5.0% and is now trading at $26.05.
View the best growth stocks for 2023 here
.

Are investors shorting First Trust Nasdaq Pharmaceuticals ETF?

First Trust Nasdaq Pharmaceuticals ETF saw a increase in short interest in the month of August. As of August 31st, there was short interest totaling 8,300 shares, an increase of 8,200.0% from the August 15th total of 100 shares. Based on an average daily trading volume, of 13,100 shares, the days-to-cover ratio is presently 0.6 days.
View First Trust Nasdaq Pharmaceuticals ETF's Short Interest
.

How often does First Trust Nasdaq Pharmaceuticals ETF pay dividends? What is the dividend yield for First Trust Nasdaq Pharmaceuticals ETF?

First Trust Nasdaq Pharmaceuticals ETF announced a quarterly dividend on Monday, June 26th. Stockholders of record on Wednesday, June 28th will be paid a dividend of $0.1179 per share on Friday, June 30th. This represents a $0.47 dividend on an annualized basis and a dividend yield of 1.81%. The ex-dividend date is Tuesday, June 27th. This is a positive change from the stock's previous quarterly dividend of $0.10.
Read our dividend analysis for FTXH
.

What does FTXH invest in?

First Trust Nasdaq Pharmaceuticals ETF is a equity fund issued by First Trust. FTXH focuses on health care investments and follows the Nasdaq US Smart Pharmaceuticals Index. The fund's investments total to approximately $21.10 million assets under management.

What stocks does First Trust Nasdaq Pharmaceuticals ETF hold?
What is the management fee for First Trust Nasdaq Pharmaceuticals ETF?

First Trust Nasdaq Pharmaceuticals ETF's management fee is 0.60% and has no other recorded expenses or fee waivers. The net expense ratio for FTXH is 0.60%.

What other stocks do shareholders of First Trust Nasdaq Pharmaceuticals ETF own?

Based on aggregate information from My MarketBeat watchlists, some companies that other First Trust Nasdaq Pharmaceuticals ETF investors own include Digirad (DRAD), RAIT Financial Trust (RAS), Cummins (CMI), Auxly Cannabis Group (CBWTF), Blueknight Energy Partners (BKEP), Biocept (BIOC), BioCorRx (BICX), BlackRock Municipal Income Trust (BFK), AmeriGas Partners (APU) and Aphria (APHA).

What is First Trust Nasdaq Pharmaceuticals ETF's stock symbol?

First Trust Nasdaq Pharmaceuticals ETF trades on the NASDAQ under the ticker symbol "FTXH."

Who are First Trust Nasdaq Pharmaceuticals ETF's major shareholders?

First Trust Nasdaq Pharmaceuticals ETF's stock is owned by many different retail and institutional investors. Top institutional investors include LPL Financial LLC (7.07%), WMG Financial Advisors LLC (4.13%), Paragon Private Wealth Management LLC (2.76%), Citadel Advisors LLC (2.42%), Cambridge Investment Research Advisors Inc. (1.56%) and Equitable Holdings Inc. (1.39%).

How do I buy shares of First Trust Nasdaq Pharmaceuticals ETF?

Shares of FTXH stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

What is First Trust Nasdaq Pharmaceuticals ETF's stock price today?

One share of FTXH stock can currently be purchased for approximately $26.05.

How much money does First Trust Nasdaq Pharmaceuticals ETF make?

First Trust Nasdaq Pharmaceuticals ETF (NASDAQ:FTXH) has a market capitalization of $24.75 million.

How many employees does First Trust Nasdaq Pharmaceuticals ETF have?

The company employs 147,000 workers across the globe.

How can I contact First Trust Nasdaq Pharmaceuticals ETF?

The company can be reached via phone at 14089961010.

This page (NASDAQ:FTXH) was last updated on 9/22/2023 by MarketBeat.com Staff

My Account -